| 1 |
31582608 | [Development of Stratified and Personalized Medicine Based on Pharmacogenomic and Pharmacokinetic Analyses]. | 2019 |
2 |
| 2 |
29273767 | The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation. | 2018 Sep |
1 |
| 3 |
29776386 | Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation. | 2018 May 18 |
1 |
| 4 |
28376131 | Dietary and genetic influences on hemostasis in a Yup'ik Alaska Native population. | 2017 |
2 |
| 5 |
28521079 | Association between CYP4F2 genotype and circulating plasma vitamin K concentration in children on chronic warfarin therapy: Possible long-term implications for bone development and vascular health. | 2017 Dec |
7 |
| 6 |
25747538 | Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy. | 2015 May |
1 |
| 7 |
25946405 | Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX. | 2015 Jul |
1 |
| 8 |
24503627 | Genetic risk factors for major bleeding in patients treated with warfarin in a community setting. | 2014 Jun |
1 |
| 9 |
24138531 | Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11. | 2013 Nov 19 |
1 |
| 10 |
22172097 | CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects. | 2012 Aug |
1 |
| 11 |
22417713 | Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study. | 2012 Apr |
4 |
| 12 |
23047901 | [Vitamin K antagonists: from discovery to pharmacogenetics]. | 2012 Oct 1 |
1 |
| 13 |
22122181 | Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. | 2011 Dec |
1 |
| 14 |
20169584 | Regulation of xenobiotic metabolism, the only signaling function of alpha-tocopherol? | 2010 May |
1 |
| 15 |
19741565 | Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy. | 2009 Oct |
2 |